Evaluation of anti tumour activity of ethanolic extract of beet root (Beta vulgaris) against EAC mouse tumor model
DOI:
https://doi.org/10.7439/ijpr.v7i3.3943Abstract
Introduction: EAC is referred to as undifferentiated carcinoma, and is originally hyper-diploid. The permeability to water is highest at the initiation of S and progressively decreases to its lowest value just after mitosis. Activation heats for water permeability vary during the cell cycle, ranging from 914 k. ca/mole. Methodology: The extraction of phytoconstituents was carried out by reflux condensation and preliminary phytochemical screening was done by various qualitative confirmatory tests. The in vivo anti tumour activity of ethanolic extract of beet root (EEBT) was carried out on EAC mouse tumour models. Results: All five animals were in both 5-FU as well as EEBT group. So mortality was less in both 5-FU and EEBT group. The Hb and RBC count were lower in tumour control group. The WBC counts were significantly increased in tumour control. 5-FU and EEBT mg/kg group decreased the WBC counts approximately near to normal range. The neutrophils were increased and lymphocytes were decreased significantly in tumour control group. The platelet count was also significantly increased in tumour control and EEBT (200 mg/kg) group compared nearly to normal group. EEBT and 5-FU significantly increased the PILS. While 5-FU increased the life span of EAC 90.90% and EEBT increased the life span of EAC 86.36%. Conclusion: From the present experimental data here we concluded that the EEBT possessed potential anti tumour activity against EAC mouse tumour model which was proved by the assessment of haematological parameters as well as by Percent increase of lifespan (% ILS). The Percent increase of lifespan ( PILS) of both standard group as well as EEBT treated group was found to be 90.90% and 86.36%.Downloads
Download data is not yet available.
Downloads
Published
2017-03-28
Issue
Section
Research Articles
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- Author must Submit Copyright form After acceptance of Article
How to Cite
1.
Kumar PS, Bhaumik A, Rao DB, Chopra M. Evaluation of anti tumour activity of ethanolic extract of beet root (Beta vulgaris) against EAC mouse tumor model. Int J of Pharmc Res [Internet]. 2017 Mar. 28 [cited 2025 Mar. 14];7(3):71-6. Available from: https://ssjournals.co.in/index.php/ijpr/article/view/3943